Article
MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.
Leukemia & lymphoma - 1 Nov 2012
Zhuo Wenlei, Zhang Liang, Ling Junjun, Zhu Bo, Chen Zhengtang
Abstract excerpt
Evidence implicates MDM2 (murine double minute-2) T309G polymorphism as a risk factor for several cancers. Increasing numbers of studies have been carried out on the association of MDM2 T309G polymorphism with susceptibility to leukemia and have generated conflicting results. The aim of the prese...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
